Journal
PERSONALIZED MEDICINE
Volume 9, Issue 4, Pages 451-455Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/PME.12.40
Keywords
breast cancer; polygenic risk; prostate cancer; stratified screening
Categories
Funding
- European Community [223175 (HEALTH-F2-2009-223175)]
- Cancer Research UK [13065] Funding Source: researchfish
Ask authors/readers for more resources
To date, risk profiles based on the known common susceptibility variants have limited value in predicting the risk of disease, but they could be used for risk stratification in prevention programs at a population level. We illustrate the potential utility of polygenic risk stratification using the case of population-based screening for prostate and breast cancer. We compared the number of individuals eligible for screening and the number of cases potentially detectable by screening in a population undergoing screening based on age alone with a population undergoing stratified screening based on age and polygenic risk profile. Stratified-screening strategies based on age and genetic risk would potentially improve the efficiency of screening programs and reduce their adverse consequences. Organizational, ethical, legal and social issues need to be addressed before stratified-screening programs could be implemented.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available